Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 35

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 35
---
 or any provisions or interpretations of the foregoing by the competent Governmental Authorities, including general principles of common and civil law and equity. “Leased Real Property” means all real property leased, licensed, subleased or otherwise used or occupied by the Company, or its Subsidiaries, as applicable. “Lien” means all liens, mortgages, deeds of trust, pledges, hypothecations, encumbrances, security interests, adverse claim, options, rights of preemption, leases, subleases, licenses, restrictions, claims or other liens of any kind whether consensual, statutory or otherwise, and whether filed, recorded or perfected under applicable Law (including any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset, but in any event excluding transfer restrictions under applicable securities Laws). “Merger” means the merging of Merger Sub with and into APx, with APx surviving such merger and becoming a direct wholly -ownedsubsidiary of the Company. “Merger Consideration” means the Company Shares and Company Warrants receivable by SPAC Shareholders pursuant to the Business Combination Agreement. “Merger Effective Time” means such time at which the Plan of Merger is registered by the Cayman Registrar in accordance with the Cayman Companies Act or at such later date and/or time permitted by the Cayman Companies Act as may be agreed by Merger Sub and SPAC in writing with the prior written consent of the Company and specified in the Plan of Merger, provided that such later time shall not be a date later than the ninetieth (90 th) day after the date when the Plan of Merger is filed and registered with the Cayman Registrar. “Merger Sub” means Heritas Merger Sub Limited, a Cayman Islands exempted company and a direct wholly -ownedsubsidiary of the Company. “MultiplAI” means MultiplAI Health Ltd, a private limited company formed under the laws of England and Wales. “MultiplAI Acquisition” means the sale and purchase of all the ordinary shares of MultiplAI Health Ltd (and, if required under the MultiplAI Share Purchase Agreement, all of the MultiplAI Shareholders’ rights and interest in the options granted to any of the MultiplAI Shareholders under all existing share option or similar option schemes of MultiplAI, and all of MultiplAI Shareholders